A case of aneurysmal ("angiomatoid") fibrous histiocytoma (AFH) in a 12-year-old girl is presented with its unusual clinicopathologic features. The lesion had the full microscopic characteristics of AFH described in prior reports, but it also had some features that differed from the original description of the disorder, such as the involvement of subcutis, its occurrence in the scalp, and a documented history of minor trauma. The lesion clinically resembled the gross features of hemangioma. The experience in the present case raises the need for considering AFH as one of major differential diagnosis of nodular cutaneous tumors in children that simulate malignancy such as angiomatoid malignant fibrous histiocytoma and Kaposi's sarcoma.
Child ; Diagnosis, Differential ; Female ; Hemangioma/pathology ; Histiocytoma, Benign Fibrous/*pathology ; Humans ; Skin Neoplasms/diagnosis/*pathology

OBJECTIVETo probe into the diagnosis and treatment of malignant fibrous histiocytoma (MFH) of the prostate.

METHODSOne case of MFH of the prostate was diagnosed and treated surgically by radical remocal of the lesion, resection of the rectum and sigmoidoctomy. The clinical features, diagnosis and treatment of MFH of the prostate were reviewed and presented.

RESULTSThe patient experienced recurrence 3 weeks after operation, and then underwent radiotherapy. Two months after operation the patient died of metastasis.

CONCLUSIONMFH of the prostate has been rare clinically, with poor prognosis. Early and aggressive surgical removal of the primary lesion followed by adjuvant therapy is recommended for the treatment of the disease.

Adult ; Biopsy ; Histiocytoma, Benign Fibrous ; diagnosis ; pathology ; therapy ; Humans ; Male ; Prostatic Neoplasms ; diagnosis ; pathology ; therapy

Primary renal malignant fibrous histiocytoma is a rare tumor of the kidney. It is clinically and radiologically indistinguishable from a renal cell carcinoma. Even following radical surgery, the tumor shows a strong predilection for local recurrence and the prognosis is generally poor. We report on a 32-year-old man with malignant fibrous histiocytoma of the kidney who remained free of recurrence for 1 year after radical nephrectomy.
Adult ; Case Report ; Histiocytoma, Fibrous/*diagnosis/pathology/surgery ; Human ; Kidney Neoplasms/*diagnosis/pathology/surgery ; Male ; Nephrectomy ; Tomography, X-Ray Computed

Primary renal malignant fibrous histiocytoma is a rare tumor of the kidney. It is clinically and radiologically indistinguishable from a renal cell carcinoma. Even following radical surgery, the tumor shows a strong predilection for local recurrence and the prognosis is generally poor. We report on a 32-year-old man with malignant fibrous histiocytoma of the kidney who remained free of recurrence for 1 year after radical nephrectomy.
Adult ; Case Report ; Histiocytoma, Fibrous/*diagnosis/pathology/surgery ; Human ; Kidney Neoplasms/*diagnosis/pathology/surgery ; Male ; Nephrectomy ; Tomography, X-Ray Computed

Adult ; Female ; Histiocytoma, Malignant Fibrous ; diagnosis ; pathology ; surgery ; Humans ; Liver Neoplasms ; diagnosis ; pathology ; surgery ; Male ; Middle Aged

Sarcomatous transformation in chordoma (dedifferentiated chordoma) is a very rare condition and has been emphasized as a distinct entity because of its more aggressive clinical course. Here we describe a case of dedifferentiated chordoma (chordoma associated with malignant fibrous histiocytoma) arising from the sacrococcygeal region of a 55-year-old woman. The results of immunohistochemical stain in the chordoma area were strong positive for cytokeratin, epithelial membrane antigen and S-100 protein. The spindle and giant cells in the transitional areas of chordoma and malignant fibrous histiocytoma were positive for cytokeratin and epithelial membrane antigen in addition to vimentin and alpha-1-antichymotrypsin. The spindle and giant cells in the central area of malignant fibrous histiocytoma were negative for cytokeratin and epithelial membrane antigen, but positive for vimentin and alpha-1-antichymotrypsin. This supports the pathogenesis of sarcomatous transformation from chordoma.
Case Report ; Chordoma/diagnosis/*pathology ; Female ; Histiocytoma, Fibrous/diagnosis/*pathology ; Human ; Immunohistochemistry ; Middle Age ; Neoplasms, Multiple Primary/*pathology ; Pelvic Neoplasms/diagnosis/*pathology

At OPD follow-up in December 1998, chest x-ray of a 42-year-old female showed a solit ary pulmonary nodule at a superior basal segment in the right lower lobe. After percut aneous transthoracic needle aspiration failure, wedge resection of the superior basal segment of lower lobe in right lung was performed for diagnosis and therapy. Three years ago, she had received surgery to remove a mass in the left buttock. The mass was pathologically diagnosed as malignant fibrous histiocytoma. She subsequently received 4500 rad radiotherapy for 35 days. Pathology confirmed metastatic malignant fibrous histiocytoma of the lung.
Adult ; Buttocks ; Diagnosis ; Female ; Follow-Up Studies ; Histiocytoma, Malignant Fibrous* ; Humans ; Lung Neoplasms ; Lung* ; Needles ; Pathology ; Radiotherapy ; Thorax

PURPOSE: Malignant fibrous histiocytoma (MFH) is mainly a soft tissue sarcoma containing fibroblast-like cells and histiocytic cells. MFH in bone accounts for 5% of all malignant bone tumors. MFH of the maxilla is extremely rare and difficult to diagnose due to its scarcity. Treatment mainstay is a complete surgical excision. Radiation therapy is also available when surgery alone is incomplete. Prognosis is not clear but can be devastating. Authors report one case of MFH developed in the maxilla. METHODS: A 24-year-old man firstly diagnosed as fibrous dysplasia based on CT findings. Considering facial contour, partial excision was done. But pathology report confirmed malignant fibrous histiocytoma and secondary wide excision was done including zygoma and grossly all affected area. After surgery, radiation therapy was continued. RESULTS: There are no evidence of tumor recurrence after clinical and radiological treatment. CONCLUSION: MFH of maxilla is very rare and this can leads to misdiagnosis in many clinicians. Surgeon should differentiate this disease from fibrous dysplasia and pathology and MRI are accurate methods for diagnosis of MFH.
Diagnosis ; Diagnostic Errors ; Facial Bones ; Histiocytoma, Malignant Fibrous* ; Humans ; Magnetic Resonance Imaging ; Maxilla* ; Pathology ; Prognosis ; Recurrence ; Sarcoma ; Young Adult ; Zygoma

Adolescent ; Adult ; Aged ; Aged, 80 and over ; Heart Atria ; pathology ; Histiocytoma, Malignant Fibrous ; diagnosis ; Humans ; Male ; Middle Aged ; Young Adult

We describe 2 cases of malignant fibrous histiocytomas (MFHs) that spontaneously developed in young pet dogs. To classify these tumors, we applied a panel of antibodies (vimentin, desmin, alpha-SMA, and ED1) and Azan staining for collagen. The MFHs were most consistent with osteoclast-like giant and inflammatory cell types. The first case had positive staining for ED1 and vimentin, and given the osteoclast-like giant cells, calcification sites accompanying peripheral giant cell infiltrates. The latter case, the inflammatory cell type, exhibited a storiform-pleomorphic variant of neoplastic cells, including an ossifying matrix. MFHs are among the most highly aggressive tumors occurring in soft tissue sarcomas in elderly dogs; however, MFHs have been poorly studied from a diagnostic point of view. Herein, we describe the histologic and immunohistologic features of MFHs in detail, thus classifying the subtypes of these tumors.
Animals ; Biopsy/veterinary ; Dog Diseases/diagnosis/*pathology ; Dogs ; Female ; Histiocytoma, Malignant Fibrous/diagnosis/pathology/*veterinary ; Immunohistochemistry/veterinary ; Male ; Soft Tissue Neoplasms/diagnosis/pathology/*veterinary